Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty

Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer Patient-Specific Instrumentation for Shoulder Arthroplasty

Catalyst OrthoScience Inc. has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Archer Patient-Specific Instrumentation (PSI). “Licensed in partnership with 3D-Side, Archer PSI is a full suite of humeral and glenoid guides tailored to the patient’s anatomy that allow orthopedic surgeons to execute their 3D preoperative plans intraoperatively with greater precision consistency, and confidence. Catalyst is one of the only …

Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty

New patient-specific solution expands Catalyst’s portfolio, enabling precise translation of 3D surgical plans into the operating room to reduce steps and increase accuracyNAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (“Catalyst”), a privat... L'articolo Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty è un contenuto originale di 01net.

Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty – Ortho Spine News

Catalyst OrthoScience’s Archer® Patient-Specific Instrumentation for shoulder arthroplasty expands the company’s portfolio, enabling precise translation of 3D surgical plans into the operating room to reduce steps and increase accuracy. NAPLES, Fla., February 25, 2026 -(BUSINESS WIRE)- Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, toda